ENIM
安特羅生物科技股份有限公司
ENIM is a Taiwan Emerging Stock Board biotechnology company; its most advanced asset is EV71 / EnVAX-A71 (Macau marketing authorization obtained, Prevention of enterovirus 71 disease in children aged 2 months to under 6 years), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| EV71 / EnVAX-A71 | — | Macau marketing authorization obtained | Prevention of enterovirus 71 disease in children aged 2 months to under 6 years | Macau | 2026-03-30 | Company disclosure |
Key events
- Business update (company filing)